Steven Cohen 89bio, Inc. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in 89bio, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,274,151 shares of ETNB stock, worth $20.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,274,151Holding current value
$20.6 Million% of portfolio
0.05%Shares
6 transactions
Others Institutions Holding ETNB
# of Institutions
212Shares Held
162MCall Options Held
289KPut Options Held
1.6M-
Janus Henderson Group PLC London, X020.8MShares$188 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$180 Million4.27% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$128 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$85.9 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$74.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $420M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...